Ownership history in VR Adviser, LLC · 13 quarters on record
This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in KALVISTA PHARMACEUTICALS INC (KALV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 6,728,985 | — | 0% | 5.37% | $108.7M | $16.15 |
| 2025 Q3 | UNCHANGED | 6,728,985 | — | 0% | 4.61% | $82.0M | $12.18 |
| 2025 Q2 | ADDED | 6,728,985 | +25,000 | +0.4% | 5.70% | $76.1M | $11.31 |
| 2025 Q1 | ADDED | 6,703,985 | +454,254 | +7.3% | 6.58% | $77.4M | $11.54 |
| 2024 Q4 | UNCHANGED | 6,249,731 | — | 0% | 3.63% | $52.9M | $8.47 |
| 2024 Q3 | UNCHANGED | 6,249,731 | — | 0% | 3.79% | $72.4M | $11.58 |
| 2024 Q2 | UNCHANGED | 6,249,731 | — | 0% | 4.69% | $73.6M | $11.78 |
| 2024 Q1 | ADDED | 6,249,731 | +2,157,000 | +52.7% | 3.53% | $74.1M | $11.86 |
| 2023 Q4 | ADDED | 4,092,731 | +1,176,064 | +40.3% | 3.44% | $50.1M | $12.25 |
| 2023 Q3 | UNCHANGED | 2,916,667 | — | 0% | 2.96% | $28.1M | $9.63 |
As of 2025 Q4 — sorted by position size